Mechanism of erythropoietin-induced hypertension

American Journal of Kidney Diseases

Volumn 33, Issue 5, 1999, Pages 821-828

  Vaziri, N D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell growth; Endothelin; Erythropoietin; Hypertension; Intracellular calcium; Intracellular magnesium; Nitric oxide; Prostaglandins; Renin angiotensin system; Vascular remodeling

Indexed keywords

ARGIPRESSIN; CALCIUM; CATECHOLAMINE; ENDOTHELIN; ERYTHROPOIETIN; MAGNESIUM; NITRIC OXIDE; PROSTAGLANDIN; VASOPRESSIN;

ARTERIAL PRESSURE; CALCIUM CELL LEVEL; CELL GROWTH; CHRONIC KIDNEY FAILURE; HEMATOCRIT; HYPERTENSION; MAGNESIUM BLOOD LEVEL; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0032962029     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70413-0     Document Type: Article

References (50)

1. JW Fisher Erythropoietin: Physiologic and pharmacologic aspects Proc Soc Exp Biol Med 216 1997 358 369
2. PA Abraham MG Macres Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin J Am Soc Nephrol 2 1991 927 936
3. FS Buckner JW Eschbach NR Haley RC Davidson JW Adamson Hypertension following erythropoietin therapy in anemic hemodialysis patients Am J Hypertens 3 1990 947 955
4. AE Raine SD Roger Effects of erythropoietin on blood pressure Am J Kidney Dis 18 1991 76 83
5. ND Vaziri XJ Zhou F Naqvi J Smith F Oveisi ZQ Wang RE Purdy Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure Am J Physiol 271 1996 E113 E122
6. AE Raine Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy Lancet 1 1988 97 100
7. HM Steffen R Brunner R Muller S Degenhardt M Pollok R Lang CA Baldamus Peripheral hemodynamics, blood viscosity, and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin Contrib Nephrol 76 1989 292 298
8. MS Neff KE Kim M Persoff G Onesti C Swartz Hemodynamics of uremic anemia Circulation 43 1971 876 883
9. J Martin S Moncada Blood pressure, erythropoietin, and nitric oxide [letter] Lancet 1 1988 644
10. CJ Kaupke S Kim ND Vaziri Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy J Am Soc Nephrol 4 1994 1874 1878
11. W Samtleben CA Baldamus J Bommer W Fassbinder B Nonnast-Daniel HJ Gurland Blood pressure changes during treatment with recombinant human erythropoietin Contrib Nephrol 66 1988 114 122
12. Blood pressure and erythropoietin Lancet 1 1988 351 352 [letter]
13. M Kusunoki K Kimura M Nakamura Y Isaka S Yoneda H Abe Effects of hematocrit variations on cerebral blood flow and oxygen transport in ischemic cerebrovascular disease J Cereb Blood Flow Metab 1 1981 413 417
14. JW Eschbach R Glenny T Robertson Normalizing the hematocrit in hemodialysis patients with EPO improves quality of life and is safe J Am Soc Nephrol 4 1993 425A (abstr)
15. A Besarab WK Bolton JK Browne JC Egrie AR Nissenson DM Okamoto SJ Schwab DA Goodkin The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [see comments] N Engl J Med 339 1998 584 590
16. JW Adamson JW Eschbach Erythropoietin for end-stage renal disease [editorial; comment] N Engl J Med 339 1998 625 627
17. M Lebel I Kingma JH Grose S Langlois Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients J Am Soc Nephrol 9 1998 97 104
18. SM Bode-Boger RH Boger M Kuhn J Radermacher JC Frolich Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin J Cardiovasc Pharmacol 20 1992 S25 S28
19. MF Hand WG Haynes HA Johnstone JL Anderton DJ Webb Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure Kidney Int 48 1995 806 813
20. ND Vaziri XJ Zhou J Smith F Oveisi K Baldwin RE Purdy In vivo and in vitro pressor effects of erythropoietin in rats Am J Physiol 269 1995 F838 F845
21. KN Lai SF Lui JC Leung E Law MG Nicholls Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis Nephron 57 1991 394 400
22. P Eggena P Willsey N Jamgotchian L Truckenbrod MS Hu JD Barrett MP Eggena K Clegg F Nakhoul DB Lee Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems Am J Physiol 261 1991 E642 E646
23. R Carlini CI Obialo M Rothstein Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients Am J Hypertens 6 1993 103 107
24. K Takahashi K Totsune Y Imai M Sone M Nozuki O Murakami H Sekino T Mouri Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin Clin Sci (Colch) 84 1993 47 50
25. RG Carlini AS Dusso CI Obialo UM Alvarez M Rothstein Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells Kidney Int 43 1993 1010 1014
26. SM Bode-Boger RH Boger M Kuhn J Radermacher JC Frolich Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids Kidney Int 50 1996 1255 1261
27. K Katoh K Mizuno S Hashimoto K Okazaki K Asahi M Kuriki D Yamada S Fukuchi Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue Life Sci 54 1994 L253 L259
28. XJ Zhou D Pandian XQ Wang ND Vaziri Erythropoietin-induced hypertension in rat is not mediated by alterations of plasma endothelin, vasopressin, or atrial natriuretic peptide levels J Am Soc Nephrol 8 1997 901 905
29. G Hon ND Vaziri CJ Kaupke A Tehranzadeh C Barton Lack of a fast-acting effect of erythropoietin on arterial blood pressure and endothelin level Artif Organs 19 1995 188 191
30. OF Wagner G Christ J Wojta H Vierhapper S Parzer PJ Nowotny B Schneider W Waldhausl BR Binder Polar secretion of endothelin-1 by cultured endothelial cells J Biol Chem 267 1992 16066 16068
31. D del Castillo L Raij PJ Shultz JP Tolins The pressor effect of recombinant human erythropoietin is not due to decreased activity of the endogenous nitric oxide system Nephrol Dial Transplant 10 1995 505 508
32. LM Resnick Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders Am J Med 93 suppl 2A 1992 S11 S20
33. S Vasdev P Thompson C Triggle P Fernandez P Bolli VS Ananthanarayanan Fura-2 used as a probe to show elevated intracellular free calcium in platelets of Dahl-sensitive rats fed a high salt diet Biochem Biophys Res Commun 154 1988 380 386
34. JM Krzesinski F Du ML Pequeux GL Rorive Plasma Na-K ATPase inhibitor activity and intracellular ions during hemodialysis Int J Artif Organs 16 1993 23 30
35. T Matuura M Kohno Y Kanayama K Yasunari K Murakawa T Takeda K Ishimori I Morishima T Yonezawa Decreased intracellular free magnesium in erythrocytes of spontaneously hypertensive rats Biochem Biophys Res Commun 143 1987 1012 1017
36. CJ Kaupke XJ Zhou ND Vaziri Cytosolic ionized magnesium concentration in end-stage renal disease: Effect of hemodialysis ASAIO J 39 1993 M614 M617
37. BM Altura BT Altura Role of magnesium in the pathogenesis of hypertension: Relationship to its actions on cardiac and vascular smooth muscle JH Laragh BM Brenner Hypertension: Pathophysiology, Diagnosis, and Management. 1990 Raven New York, NY 1003 1025
38. C Van Geet R Van Damme-Lombaerts M Vanrusselt A de Mol W Proesmans J Vermylen Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: A possible link? Thromb Haemost 64 1990 7 10
39. M Neusser M Tepel W Zidek Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells Cardiovasc Res 27 1993 1233 1236
40. H Karaki Ca2+ localization and sensitivity in vascular smooth muscle Trends Pharmacol Sci 10 1989 320 325
41. TM Lincoln TL Cornwell Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation Blood Vessels 28 1991 129 137
42. MB Marrero RC Venema H Ma BN Ling DC Eaton Erythropoietin receptor-operated Ca2+ channels: Activation by phospholipase C-gamma Kidney Int 53 1998 1259 1268
43. BA Miller JY Cheung Mechanisms of erythropoietin signal transduction: involvement of calcium channels Proc Soc Exp Biol Med 206 1994 263 267
44. ND Vaziri Z Ni XQ Wang F Oveisi XJ Zhou Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH Am J Physiol 274 1998 F642 F649
45. Z Ni XQ Wang ND Vaziri Nitric oxide metabolism in erythropoietin-induced hypertension: Effect of calcium channel blockade Hypertension 32 1998 724 729
46. S Heidenreich KH Rahn W Zidek Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels Kidney Int 39 1991 259 265
47. RG Carlini AA Reyes M Rothstein Recombinant human erythropoietin stimulates angiogenesis in vitro Kidney Int 47 1995 740 745
48. J Gogusev DL Zhu T Herembert F Ammarguellat P Marche T Drueke Effect of erythropoietin on DNA synthesis, proto-oncogene expression and phospholipase C activity in rat vascular smooth muscle cells Biochem Biophys Res Commun 199 1994 977 983
49. F Ammarguellat J Gogusev TB Drueke Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor Nephrol Dial Transplant 11 1996 687 692
50. Wang XQ, Vaziri ND: Erythropoietin depresses nitric oxide synthase expression by cultured human endothelial cells. Hypertension (in press)